Your browser doesn't support javascript.
loading
Complete Response to Aflibercept-FOLFIRI in One Patient With Colorectal Cancer Refractory to Bevacizumab-FOLFOX: A Possible Autocrine Vascular Endothelial Growth Factor Receptor 2-Related Mechanism.
Kim, Stefano; Cayre, Anne; Jary, Marine; Jacquin, Marion; Arbez-Gindre, Francine; Fein, Francine; Lakkis, Zaher; Nguyen, Thierry; Borg, Christophe.
Afiliação
  • Kim S; Department of Medical Oncology, University Hospital of Besançon, Besançon, France; Clinical Investigational Center, CIC-1431, University Hospital of Besançon, Besançon, France; INSERM, Unit 1098, University of Bourgogne Franche-Comté, Besançon, France. Electronic address: chkim@chu-besancon.fr.
  • Cayre A; Department of Pathology, Jean Perrin Center, Clermont-Ferrand, France.
  • Jary M; Department of Medical Oncology, University Hospital of Besançon, Besançon, France; Clinical Investigational Center, CIC-1431, University Hospital of Besançon, Besançon, France; INSERM, Unit 1098, University of Bourgogne Franche-Comté, Besançon, France.
  • Jacquin M; Clinical Investigational Center, CIC-1431, University Hospital of Besançon, Besançon, France.
  • Arbez-Gindre F; Department of Pathology, University Hospital of Besançon, Besançon, France.
  • Fein F; Department of Gastroenterology, University Hospital of Besançon, Besançon, France.
  • Lakkis Z; Department of Digestive Surgery and Liver Transplantation, University Hospital of Besançon, Besançon, France.
  • Nguyen T; Department of Medical Oncology, University Hospital of Besançon, Besançon, France.
  • Borg C; Department of Medical Oncology, University Hospital of Besançon, Besançon, France; Clinical Investigational Center, CIC-1431, University Hospital of Besançon, Besançon, France; INSERM, Unit 1098, University of Bourgogne Franche-Comté, Besançon, France.
Clin Colorectal Cancer ; 15(4): e229-e234, 2016 12.
Article em En | MEDLINE | ID: mdl-27600470

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas Recombinantes de Fusão / Camptotecina / Neoplasias Colorretais / Protocolos de Quimioterapia Combinada Antineoplásica / Inibidores da Angiogênese / Receptores de Fatores de Crescimento do Endotélio Vascular / Receptor 2 de Fatores de Crescimento do Endotélio Vascular / Bevacizumab Tipo de estudo: Prognostic_studies Limite: Humans / Male / Middle aged Idioma: En Revista: Clin Colorectal Cancer Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas Recombinantes de Fusão / Camptotecina / Neoplasias Colorretais / Protocolos de Quimioterapia Combinada Antineoplásica / Inibidores da Angiogênese / Receptores de Fatores de Crescimento do Endotélio Vascular / Receptor 2 de Fatores de Crescimento do Endotélio Vascular / Bevacizumab Tipo de estudo: Prognostic_studies Limite: Humans / Male / Middle aged Idioma: En Revista: Clin Colorectal Cancer Ano de publicação: 2016 Tipo de documento: Article